Detalhe da pesquisa
1.
Markers of thrombin generation are associated with myocardial necrosis and left ventricular impairment in patients with ST-elevation myocardial infarction.
Thromb J
; 13: 31, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26396552
2.
Safety considerations of polyunsaturated fatty acids.
Am J Clin Nutr
; 71(1 Suppl): 197S-201S, 2000 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-10617971
3.
Long-term metabolic effects of n-3 polyunsaturated fatty acids in patients with coronary artery disease.
Am J Clin Nutr
; 61(4): 831-6, 1995 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-7702027
4.
Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin.
Atherosclerosis
; 166(2): 279-84, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12535740
5.
Reduced levels of TNF alpha in hypercholesterolemic individuals after treatment with pravastatin for 8 weeks.
Atherosclerosis
; 157(2): 411-5, 2001 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-11472741
6.
Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency.
Am J Cardiol
; 77(1): 31-6, 1996 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-8540453
7.
Influence of serum lipoprotein(a) and homocyst(e)ine levels on graft patency after coronary artery bypass grafting.
Am J Cardiol
; 74(11): 1099-102, 1994 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-7977066
8.
Global fibrinolytic capacity assessed by the serum D-dimer test. Correlation between basal and stimulated values.
Thromb Res
; 75(2): 157-62, 1994 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-7974389
9.
Influence of highly concentrated n-3 fatty acids on serum lipids and hemostatic variables in survivors of myocardial infarction receiving either oral anticoagulants or matching placebo.
Thromb Res
; 53(5): 467-74, 1989 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-2660319
10.
Effect of long-term, moderate-dose supplementation with omega-3 fatty acids on monocyte procoagulant activity and release of interleukin-6 in patients with coronary artery disease.
Thromb Res
; 77(4): 337-46, 1995 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-7740525
11.
Effects of long-term treatment with warfarin on fibrinogen, FPA, TAT, and D-dimer in patients with coronary artery disease.
Thromb Res
; 66(1): 55-60, 1992 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-1412183
12.
Effects of fish oil, nifedipine and their combination on blood pressure and lipids in primary hypertension.
J Hum Hypertens
; 7(1): 25-32, 1993 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-8450517
13.
Long-term prognosis after out-of-hospital cardiac arrest and primary percutaneous coronary intervention.
Resuscitation
; 63(1): 49-53, 2004 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-15451586
14.
Long-term effects of n-3 polyunsaturated fatty acids on haemostatic variables and bleeding episodes in patients with coronary artery disease.
Blood Coagul Fibrinolysis
; 6(1): 17-22, 1995 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-7795149
15.
Postconditioning in ST-elevation myocardial infarction: a systematic review, critical appraisal, and meta-analysis of randomized clinical trials.
Vasc Health Risk Manag
; 10: 477-91, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25143742
16.
Ethnicity and acute myocardial infarction: risk profile at presentation, access to hospital management, and outcome in Norway.
Vasc Health Risk Manag
; 8: 505-15, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22956878
17.
Elevated levels of PAI-1 activity and t-PA antigen are associated with newly diagnosed abnormal glucose regulation in patients with ST-elevation myocardial infarction.
J Thromb Haemost
; 9(8): 1468-74, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21624046
18.
Activated protein C resistance and graft occlusion after coronary artery bypass surgery.
Thromb Res
; 79(2): 223-6, 1995 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-7676409
19.
Acute myocardial infarction and thyrotoxic storm--a difficult and dangerous combination.
Acta Anaesthesiol Scand
; 49(5): 707-11, 2005 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15836689
20.
Insulin and PAI-1 levels during oral glucose tolerance test in patients with coronary heart disease.
Scand J Clin Lab Invest
; 54(3): 241-6, 1994 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-8036449